tiprankstipranks
Atara Biotherapeutics (GB:0HIY)
LSE:0HIY
UK Market

Atara Biotherapeutics (0HIY) Income Statement

Compare
1 Followers

Atara Biotherapeutics Income Statement

Last quarter (Q3 2024), Atara Biotherapeutics's total revenue was $40.19M, an increase of 1779.79% from the same quarter last year. In Q3, Atara Biotherapeutics's net income was $-21.91M. See Atara Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 128.94M$ 8.57M$ 63.57M$ 20.34M$ 0.00
Gross Profit
$ 107.93M$ -313.00K$ 49.01M$ 8.96M$ -9.87M
Operating Expenses
$ 191.37M$ 275.69M$ 344.09M$ 360.80M$ 309.05M
Depreciation and Amortization
$ 0.00$ 4.83M$ 14.57M$ 11.38M$ 9.87M
EBITDA
$ -83.44M$ -266.00M$ -213.72M$ -331.12M$ -296.74M
Operating Income
$ -83.44M$ -276.01M$ -280.51M$ -340.46M$ -309.05M
Other Income/Expenses
$ -1.98M$ -105.00K$ 52.22M$ 367.00K$ 2.45M
Pretax Income
$ -85.42M$ -276.11M$ -228.29M$ -340.10M$ -306.61M
Net Income
$ -85.40M$ -276.13M$ -2.28B$ -3.40B$ -3.07B
Per Share Metrics
Basic EPS
$ -11.41$ -65.18$ -55.96$ -90.78$ -103.63
Diluted EPS
$ -11.41$ -65.18$ -55.96$ -90.78$ -103.63
Weighted Average Shares Outstanding
7.49M 4.24M 4.08M 3.75M 2.96M
Weighted Average Shares Outstanding (Diluted)
7.49M 4.24M 4.08M 3.75M 2.96M
Currency in USD

Atara Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis